The global medical electrodes market size is prophesied to reach USD 822.13 million by 2027 on account of the rising prevalence of cardiovascular diseases worldwide. Medical electrodes are used for transferring energy of ionic currents in the body into electrical currents that can be utilized for studying, and amplifying and further utilized for diagnosis of a disease. A recently published report by Fortune Business Insights offers an elaborate overview of the market and its growth parameters. According to the report titled, “Medical Electrodes Market Size, Share & Industry Analysis, By Product (Wet Electrodes, Dry Electrodes, Needle Electrodes), By Application (Cardiology, Neurophysiology, Others) By Usage (Disposable Medical Electrodes, Reusable Medical Electrodes) By End User (Hospitals & Ambulatory Surgery Centers (ASCs), Specialty Clinics & Diagnostics Centers) and Regional Forecast, 2020-2027,” the market stood at USD 609.76 million in 2019 and will exhibit a CAGR of 3.9% during the forecast period, 2020 to 2027.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/medical-electrodes-market-102729
What are the Objectives of the Report?
The report is based on a quantitative and qualitative analysis of the market and focuses on parameters such as drivers, restraints, challenges, and future opportunities. It also offers insights into the market, current trends, and significant industry developments of the market. The report further discusses the table of segmentation based on factors such as product, application, Usage, end-user, and regions and lists the names and expected shares of the leading segments. It provides a list of key players operating in the market and the major strategies adopted by them to gain a competitive edge in the market. The report is available for sale on the company website.
Market Drivers
Rising Prevalence of Neurological Disorders will Add Impetus to Market
The rising prevalence of cardio and neurological disorders are the key medical electrodes market growth drivers. Additionally, government support from various nations in the form of regulatory scenario, and reimbursement policies will also help promote the growth of the market in the long run. On the contrary, factors such as lack of awareness about associated technological advancements and benefits of these devices may cause hindrance to the overall growth of the market.
Regional Segmentation:
Increasing Reimbursement Policies and Better Healthcare Facilities will Help North America Dominate Market
Regionally, North America earned a revenue of USD 280.46 million in 2019 and emerged dominant. Factors responsible for this growth include the rise in government initiatives for enhancing the healthcare sector and medical facilities in the region, coupled with the reimbursement policies and flexible regulatory scenario. On the other side, the Asia Pacific market will rise at a rapid CAGR in the forecast period on account of rising penetration of new vendors into the regional market, coupled with the rise in expenditure on healthcare infrastructure and equipment development in the emerging economies such as India, China, and others. Furthermore, the increasing prevalence of chronic diseases that ails efficient diagnosis such as neurological disorders and cardiac issues will help Latin America and the Middle East and Africa markets witness stable growth.
More Trending Topics from Fortune Business Insights:
Surgical Robots Market, Share, Growth, Sales and Drivers Analysis Research Report 2026
The global lymphoma treatment market size is predicted to reach USD 13.11 billion by 2026, exhibiting a CAGR of 8.3% during the forecast period. The increasing R&D investments for strong pipeline candidates by prominent players will contribute positively to the lymphoma treatment market revenue in the forthcoming years. For instance, Agios Pharmaceuticals, Inc. announced its clinical trial Phase I for a pipeline candidate called AG-636. The new drug will be used to treat indications of lymphoma. The growing concentration on oncology therapeutics owing to the rising cases of lymphoma in individuals will enable healthy growth of the market in the forthcoming years. According to the published report by Fortune Business Insights, titled “Lymphoma Treatment Market Size, Share & Industry Analysis, By Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, and Others), By Disease Type (Non-Hodgkin Lymphoma, and Hodgkin Lymphoma), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies& Drug Stores, and Online Pharmacies), and Regional Forecast, 2019-2026” the market size stood at USD 6.94 billion in 2018
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/lymphoma-treatment-market-100262
Market Driver:
Rising Cases of Blood Cancer to Spur Market Opportunities
The increasing prevalence of cancers of different forms, including blood cancer will aid the lymphoma treatment marketgrowth during the forecast period. The growing necessity for advanced and effective therapeutics can be a crucial factor in boosting the lymphoma treatment markettrends. For instance, lymphomas usually have no to minimal symptoms till the cancer hits the last stage and, in that period, an aggressive and efficient therapeutics is required for better clinical outcomes. Furthermore, the requirement for pretreatment options to administer advanced therapeutics in patients for the treatment of lymphoma will enable healthy growth of the market in the foreseeable future. In addition, the demand for enhanced and better clinical outcomes for patients will create business opportunities for this marketduring the forecast period.
Regional Analysis:
Adoption of Advanced Therapeutics to Augment Growth in North America
The lymphoma treatment market in North America stood at USD 3.33 billion in 2018 and is predicted to remain dominant during the forecast period. The growing in the region is attributed to higher diagnosis and treatment rates for all these types of cancers. The increasing prevalence of lymphoma along with high adoption of advanced therapeutics will enable growth in the region during the forecast period. The rising awareness about new treatment options among patient population further favor growth in the region. In addition, the presence of major clinical stage biopharmaceutical companies along with various drugs in pipeline candidates will aid expansion in North America. The market in Europe and Asia-Pacific is projected to hold significant share in the forthcoming years owing to the new regulatory approvals of key products in the regions. The launch of advanced therapeutics, for instance, Kymriah (tisagenlecleucel) by Novartis AG and is used for the treatment of B‑cell precursor acute lymphoblastic leukemia. The presence of a large patient population along with prevalence of cancer will aid growth in Asia Pacific. However, limited healthcare expenditure of regions such as Latin America and the Middle East will restrict the growth of the market.
More Trending Topics from Fortune Business Insights:
The global blood group typing market size is projected to reach USD 2.68 billion by 2027, exhibiting a CAGR of 7.2% during the forecast period. Rising prevalence of anemia worldwide is set to fuel the growth of this market, shares Fortune Business Insights™ in its report, titled “Blood Group Typing Market Size, Share & Industry Analysis, By Product (Instruments, and Reagents & Kits), By Test Type (ABO Tests, Antigen Typing, Antibody Screening, Cross-matching Tests, and HLA Typing), By Techniques (Serology Tests, and Molecular Tests), By End User (Hospital-based Laboratories, and Independent Laboratories & Blood Banks), and Regional Forecast, 2020-2027”.World Health Organization (WHO) data reveals that nearly 1.62 billion people, or 24.8% of the global population, are affected by anemia. Anemia is the deficiency of healthy red blood cells (RBCs) in the body, which leads to lack of oxygen supply to the organs. As a result, anemic people need to undergo regular blood transfusion exercises to maintain a stable RBC count in the body. Blood transfusion process requires blood typing tests to ensure compatibility between the donor’s and recipient’s blood type. Thus, growing incidence of anemia and the subsequent rising demand for blood transfusion will lead the blood group typing market trends in the foreseeable future.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/blood-group-typing-market-101767
Market Restraint
Fears Arising from Covid-19 Pandemic to Severely Affect Blood Collection Globally
Voluntary blood donations are a prerequisite for patients suffering from chronic blood disorders as a higher stock of blood samples increases the probability of finding matching blood types for such individuals. Unfortunately, the COVID-19 outbreak has led to a drastic decline in voluntary blood donations across the globe, resulting from fears associated with the safety standards of the equipment used and imposition of lockdowns in most countries. Health systems in many countries have begun sounding alarm bells as existing stock of blood has started falling. For instance, the UK’s National Health Service (NHS) reported in March 2020 that voluntary donations fell by 15%. Similarly, in India, the Rotary Blood Bank and the Indian Red Cross Society declared that they were facing a shocking 80% shortfall of blood collection. Such sudden dips in blood donations are likely to have unfathomable effects on the patients suffering from diseases such as thalassemia and hemophilia, which require regular blood transfusions. Since the efficacy of blood typing mechanisms is heavily dependent on blood donations, a fall in these activities will negatively impact the blood group typing market growth.
Regional Analysis
North America to Lead the Market Supported by Rapid Adoption of Advanced Blood Typing Tests
With a market size of USD 572.0 million, North America is set to dominate the blood group typing market share during the forecast period. This is mainly attributable to the high adoption rate of advanced blood typing tests and methods in the region. Additionally, players operating in the region are provided adequate regulatory support, which has created conducive environment for innovation in the healthcare sector. Europe is anticipated to register an impressive CAGR on account of rising demand for safe blood transfusion techniques, while Asia-Pacific is slated to showcase considerable growth owing to increasing prevalence of chronic conditions such as anemia.
More Trending Topics from Fortune Business Insights:
The Dental Crowns and Bridges Market is likely to gain momentum from the rising usage of digital dentistry. Presently, masses at are choosing various digital equipment, such as milling machines, computer software, scanners, and radiological devices for restorative and preventive dentistry. Teeth structures are also being customized by using CAD/CAM, as well as 3D printing technologies. This information is published by Fortune Business Insights™ in a recent report, titled, “Dental Crowns and Bridges Market Size, Share & Industry Analysis, By Type (Crowns, and Bridges), By Material (Ceramics, Porcelain Fused to Ceramics, and Metals), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the Dental Crowns and Bridges Market size was USD 2.85 billion in 2018 and is projected to reach USD 4.56 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/dental-crowns-and-bridges-market-102714
Drivers & Restraints-
Increasing Prevalence of Tooth Decay to Bolster Growth
One of the major growth drivers of the market includes the rising incidence of tooth decay and periodontal diseases. Dental caries is considered to be a significant burden and it is capable of affecting people throughout their lives, causing discomfort, disfigurement, and pain. Hence, it requires immediate medical attention. The World Health Organization stated that worldwide, approximately 3.9 billion people were affected in 2018 by oral diseases. These are mainly occurring because of poor oral hygiene, as well as rising consumption of alcohol, tobacco, sugar, and practicing an unhealthy diet.However, these dental procedures involve spending hefty amount of money. It may hinder the dental caps & bridges market growth during the forthcoming years.
Segment
Ability to Provide Lucent Finish will Drive Growth of the Ceramics Segment
Based on material, the market is grouped into metals, porcelain fused to metals, and ceramics. Out of these, the ceramics segment held 55.2%Dental Crowns and Bridges Market share in 2018 and is anticipated to remain dominant throughout the forecast period. This growth is attributable to the ability of ceramics to provide an attractive lucent finish to bridges and crowns. Also, they possess a similar aesthetic appearance to the original tooth. They are also strong and tough in nature and therefore, can be customized as per the patient’s requirement.
Regional Analysis-
Rising Geriatric Population to Favor Growth in Europe
Geographically, the market is divided into the Middle East and Africa, Europe, Latin America, North America, and Asia Pacific. Amongst these, Europe procured USD 1.16 billionDental Crowns and Bridges Marketrevenue in 2018. This growth is attributable to the higher adoption of digital dentistry equipment, surging dental expenditures, and rising geriatric population. Also, increasing and treatment and diagnosis rate for various dental disorders would propel growth of the market in this region.
North America would remain in the second position after Europe because of the availability of cutting-edge technologies, extensive health insurance coverage, and high spending on healthcare.Asia Pacific, on the other hand, is expected to showcase a significantly high CAGR in the coming years backed by the growing per capita expenditure, rising awareness programs regarding cosmetic dentistry products, and reforms in the healthcare industry.
More Trending Topics From Fortune Business Insights@
Medical Robotic Systems Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global E-prescribing market size is projected to reach USD 4,017.79 million by 2026 owing to the implementation of e-prescribing software in the electronic health record solutions that simplified prescription filling over the years. E-prescribing or electronic prescribing is a technology substructure that allows physicians and medical practitioners to send computer-based electronically generated prescriptions to a hospital-based or standalone pharmacy. It is also cost-efficient and reduces the chances of medication errors by pharmacists. The market is discussed in details in a recently published report by Fortune Business Insights™ titled, “E-prescribing Market Size, Share & Industry Analysis, By Delivery Mode (Web-based, On-premise), By Prescription Type (Controlled substance, Non controlled Substances) By End User (Hospitals, Physician's offices, Pharmacies) and Regional Forecast, 2019-2026.”As per this report, the market value was USD 863.64 million in 2018 and is expected to rise at a CAGR of 21.0 % in the forecast duration set between 2019 to 2026.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/e-prescribing-market-102698
What are the Report Highlights?
The report is based on an in-depth analysis of the market and provides a 360-degree overview of the same. It throws light on significant industry developments, current e-prescribing market trends, and other interesting insights into the market. It discusses factors boosting, repelling, challenging, ad creating opportunities for the market during the forecast period. The report also describes the table of segmentation in detail and mentions the names and figures of the leading segments with their attributed factors. For more information on the report, log on to the company website.
Market Drivers
Better Medical Record-Keeping Factor with Electronic-Prescription Solutions to Add Impetus to Market
The increasing adoption of e-prescription based electronic health record (EHR) solutions on a global basis is the key factor boosting the e-prescription market growth. Besides this, electronic prescription system offers better medical history records than handwritten prescriptions. It cannot be forged or exploited, thereby adding to the growth of the market in the forthcoming years. Additionally, rising initiatives taken by both public and private healthcare organizations to integrate e prescribing solutions and eliminate the use of adverse drug events (ADEs) and medical errors will also help to aid in the expansion of the market in the forecast period.
Regional Segmentation:
North America Dominating Market with Increasing Digitization in Healthcare Sector
Based on geographical segmentation, the market is dominated by North America, with a USD 399.61 million e-prescribing market share earned in 2018. Factors responsible for this dominance include the rise in digitalization in the healthcare sector and government-supported reimbursement policies with the flexible regulatory scenario. Additionally, the increasing funding from public and healthy private organizations with integrated adoption of EHR will help this region continue dominating the market in the coming years. On the other side, the market in Asia Pacific will witness exponential growth on account of the rising penetration of players in this region, especially in the emerging economies of China and India. Additionally, the increasing awareness about healthcare facilities and its associated benefits, coupled with the rising prevalence of chronic disorders, will help the market in the Middle East and Africa, witness stable growth.
More Trending Topics From Fortune Business Insights@
U.S. Reading Glasses Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global hydroxychloroquine market size is projected to reach USD 2,339.1 million by the end of 2027. The increasing incidence of COVID-19 infection will bode well for the market in the coming years. According to a report published by Fortune Business Insights, titled “Hydroxychloroquine Market Size, Share & Industry Analysis, By Disease Indication (Malaria, COVID-19, Rheumatoid Arthritis, Others), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027,” the market was worth USD 894.0 million in 2019 and will exhibit a CAGR of 5.5% during the forecast period, 2020-2027.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/hydroxychloroquine-market-102706
Increasing Efforts Taken to Maximize the Production Will Aid Market Growth
The report encompasses several factors that have contributed to the growth of the market in recent years. The ability of hydroxychloroquine to speed up recovery processes in treatment of patients suffering from diseases such as malaria and rheumatoid arthritis has contributed to the growing demand for the product. The increasing product demand has encouraged several companies to enhance their production methods as well as capabilities associated with the product. The report labels several companies that have taken several steps to increase the production of hydroxychloroquine during the coronavirus pandemic. In April 2020, Zydus Candila announced that it has scaled up the production of hydroxychloroquine. The company was encouraged by the sudden rise in the demand for the product; a factor that was consequential to the constantly rising Covid-19 cases across the world. Zydus’ latest step will have a huge impact on the growth of the overall market in the coming years.
Asia Pacific Likely to Emerge Dominant; Increasing Production of Hydroxychloroquine Will Aid Market Growth
The report analyzes the ongoing market trends across North America, Latin America, Asia Pacific, the Middle East and Africa, and Europe. Among these regions, the market in Asia Pacific is likely to emerge leading. The high production of the product in several countries across this region will aid the growth of the regional market. India is currently the largest producer of hydroxychloroquine, with over 70% of the global production occurring in the country. As of 2019, the market in Asia Pacific was worth USD 346.9 million and this value is projected to increase further in the coming years. Besides Asia Pacific, the market in North America will also witness considerable growth due to the increasing incidences of coronavirus in the United States.
More Trending Topics From Fortune Business Insights@
Genomics Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The increasing need for effective waste management is a key factor driving the global sharps containers market , says Fortune Business Insights in a report, titled “Sharps Containers Market Size, Share & Industry Analysis, By Product Type (Multipurpose Containers, Patient Room Containers, Phlebotomy Containers), By Waste Generators (Hospitals, Other Healthcare Providers, Pharmacies, Academic & Research Institutes, Pharmaceutical Companies, and Others), By Usage (Reusable Containers, and Single Use Containers), By Waste Type (Sharps Waste, Infectious Waste, Non-infectious Waste, and Pharmaceutical Waste), By Size (1–2 Gallons, 2–4 Gallons, 4–8 Gallons and Others) and Regional Forecast, 2019-2026.” The global sharps containers market was valued at USD 449.1 Million in 2018 and is expected to reach USD 624.1 Million by 2026 at a CAGR of 4.2%.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/sharps-containers-market-101499
Rising Government Initiatives Regarding Medical Waste Management Will Enable Growth
The rising need for effective medical waste management is expected to boost the global sharps containers market revenue during the forecast period. The increasing government efforts in implementing guidelines for effective disposal of medical waste will stimulate the growth of the global sharps containers market. For instance, World Health Organization (WHO) along with other regulatory bodies in the countries worldwide, have set standard guidelines for disposal and management of biomedical waste. It has become a mandate for all the pharmaceutical companies, research institutes, hospitals, and other healthcare providers to comply with the set of guidelines given by the governing bodies.
Partnership of PureWay With Safe Needle Disposal Will Favor Growth
PureWay ,a health-focused organization specializing in medical waste management and compliance solutions, announced its partnership with Safe Needle Disposal, a non-profit devoted to educating the public about safe needle disposal programs. At-home sharps injectors will give access to a user-friendly informational resource and regulatory experts to help answer all their sharps-related questions. It will also responsibly and affordably dispose of needles with new Safe Needle Disposal. The introduction of At-home sharps injectors will support the global sharps containers growth during the forecast period.
Furthermore, the acquisition of Daniels Healthcare Group by MAUSER is expected to create new growth opportunities for the global sharps containers market. For Instance, MAUSER Group announced the acquisition of Daniels Healthcare Group. Daniels Healthcare manufactures and markets medical waste containers for hospitals, surgeries, and the clinical waste industry.
More Trending Topics From Fortune Business Insights@
Plasma Fractionation Market ,Share, Growth, Sales and Drivers Analysis Research Report 2026
The global aesthetic lasers market is expected to gain impetus from a rise in the demand for non-invasive aesthetic treatments across the world. In a published report by Fortune Business Insights, titled, “Aesthetic Lasers Market Size, Share & Industry Analysis, By Application (Hair Removal, Pigmentation & Tattoo Removal, Body Shaping & Tightening, Skin rejuvenation, Acne Reduction, and Others), By End User (Hospitals and Specialty Clinics) and Regional Forecast, 2019-2026,” the global aesthetic lasers marketis projected to reach USD 6.06 Billion by 2026, exhibiting a CAGR of 16.6% during the forecast period. However, the global market was valued at USD 1.78 Billion in 2018.The global aesthetic lasers market will also register growth due to the increasing prevalence of skin diseases and sedentary lifestyle
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/aesthetic-cosmetic-lasers-market-101530
Increasing Number of Laser Treatment Clinics to Propel Spas and Specialty Clinics Segment
In terms of end-user, the global aesthetic lasers market is grouped into hospitals and medical spas and specialty clinics. Out of these, the medical spas and specialty clinics sub-segment is projected to dominate the global aesthetic lasers market during the forecast period. It will occur due to a rise in the number of businesses, such as skin clinics and laser treatment clinics across the world.
Demand for Hair Removal Treatment Options Likely to Boost Global Market
The International Journal of Reproduction, Contraception, Obstetrics, and Gynecology mentions that in October 2018, a rise in the incidence of the polycystic ovarian syndrome (PCOS) in India is from 3.7% to 22.5% and even up to 36% in youngsters.PCOS causes abnormal hair growth, which is increasing the demand for hair removal treatment options. It will,in turn, contribute to a rise in the global aesthetic lasers market sales in the forthcoming years.
Hologic LaunchesTempSure Firm Handpiece and Petite Mask for SculpSure Submental Treatment
Hologic, Inc., a prominent medical device company, headquartered in the U.S., announced the launch of two new products for effective treatment of aesthetic treatments in June 2019. The products were launched under the company’s Cynosure division. The two products are a petite mask and a TempSure Firm handpiece for SculpSure submental treatments. The FDA has approved the SculpSure submental treatment for patients whose body mass index is up to 49. It is the highest BMI clearance in the market for the treatment procedure. The TempSure Firm handpiece provides monopolar radiofrequency energy from unique message heads to decrease the appearance of cellulite and heat the tissue gently. It is a 60mm handpiece that allows the clinicians to treat larger portions of a patient’s body efficiently without any downtime or surgical procedure.
More Trending Topics From Fortune Business Insights@
Mass Spectrometer Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global dialysis market size is projected to reach USD 136.15 billion by 2026. The increasing investment in the research and development of new products will have a huge impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Dialysis Market Size, Share and Global Trend By Type (Products and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers& Hospitals and Home Care), and Geography Forecast till 2026,” the market was worth USD 92.78 billion in 2018 and will exhibit a CAGR of 4.9% during the forecast period, 2019-2026.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information:https://www.fortunebusinessinsights.com/dialysis-market-102367
Dialysis is a process that is carried out in patients with kidney failures. The process is used to regulate all the processes that is carried out by the kidney. The increasing incidence of chronic kidney failure will open up a huge potential for the companies operating in the market. Recent advancements in dialysis equipment have led to optimum product efficacies. Due to the high prevalence of chronic kidney diseases, several large scale companies are looking to invest more towards the development of efficient equipment. Moreover, the increasing number of regulatory clearances will create several opportunities for the market. Improving accessibility to efficient hemodialysis care centres will lead to a wider adoption for the procedure across the world. Presence of favourable reimbursement policies will contribute to the growth of the market in the coming years.
Increasing Number of Regulatory Approvals Will Aid Growth
The report includes several factors that have contributed to the growth of the market in recent years. The increasing number of regulatory approvals have made a huge impact on the growth of the market. Due to the high prevalence of kidney diseases, companies are looking to invest more in the development of advanced dialysis equipment. In October 2019, the US Food and Drug Administration announced that it has cleared Fresenius Medical’s new dialysis system. Fresenius’ device will not only help the company generate substantial market revenue, but will also have a direct impact on the growth of the market, accounting to its global customer reach.
North America to Emerge Dominant; Presence of Favorable Reimbursement Policies Will Aid Growth
The report analyzes the ongoing dialysis market trends across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years, driven by the presence of favorable health reimbursement policies in several countries across the region. As of 2018, the market in North America was worth USD 34.81 billion in 2018 and this value is projected to increase further in the coming years.
More Trending Topics from Fortune Business Insights:
Immunology Market, Share, Growth, Sales and Drivers Analysis Research Report 2026
The global medical transcription software market will benefit from the growing penetration of technology and automation in several applications across the healthcare industry. According to a report published by Fortune Business Insights, titled “Medical Transcription Software Market Size, Share & Industry Analysis, By Deployment (Cloud/Web-based and Installed/On-Premises), By End User Facility (Hospitals, Diagnostic Centers, Clinics, and Others), By Type (Voice Capture and Voice Recognition), By End User (Radiologists, Surgeons, Clinicians, and Others) and Regional Forecast, 2019-2026,” the market was valued at USD 1.17 Billion in 2018, and is projected to reach USD 3.84 Billion by 2026, exhibiting a CAGR of 16.5% during the forecast period.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/medical-transcription-software-market-101572
Technological Advancements Have Been Integral to Market Growth
Recent technological advancements in medical transcription software are favoring the market growth. Factors such as reduced costs and easy-to-use nature of the software have led to high adoption of the product across the world. The advancements made in cloud services and their incorporation in medical transcription software has made a massive influence on the growth of the market in a positive way. The benefits offered by cloud, coupled with their cost-effective nature will aid market growth. As a result, several companies are now focusing on integrating cloud services into their patented software. In 2018, Speech Processing Solutions announced the launch of a new version of SpeechLive. The product was used to convert live voice notes into text and possessed stand-out features; the primary reason behind its worldwide popularity. Fortune Business Insights has predicted that the company’s latest product will not only help generate high revenue but will also have a positive impact on the overall medical transcription software market figures.
Driven by Favorable Government Regulations, North America to Establish a Dominance
Based on regional demographics, the report classifies the market into Europe, Asia Pacific, North America, Latin America, the Middle East and Africa, and North America. Among these regions, Fortune Business Insights has predicted North America to hold the higest market share in the coming years. The regulations imposed by governing bodies in this regions have emerged in favor of the use of this software. Moreover, increasing investment in cloud development and deployment will contribute to the growth of the market in North America. As of 2018, the medical transcription software market in North America was valued at USD 562.2 Million and this value is likely to increase at a rapid pace driven by the aforementioned factors.
More Trending Topics From Fortune Business Insights@
U.S. Biosimilars Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global disposable medical gloves market value is projected to touch USD 10.9 billion by 2026, registering a modest CAGR of 9.1%. One of the major drivers for this growth is the heightened risk of chronic diseases across the world. According to the Global Burden of Disease Study 2017 conducted by the World Health Organization (WHO) and Institute of Health Metrics Evaluation (IHME), chronic (non-communicable) diseases caused 80% of the disabilities in 2017. The WHO further predicts that chronic diseases will be responsible for 60% of the global burden of disease by 2020. Most of these diseases, such as COPD and diabetes, are a result of faulty lifestyle habits, namely, lack of exercise, unhealthy diets, and smoking. The global disposable medical gloves market stands to gain from these developments in the coming decade.
Fortune Business Insights shares interesting perspectives in its report, titled “Disposable Medical Gloves Market Size, Share & Industry Analysis, By Application (Surgical and Examination), By Material (Latex and Synthetic),By Category (Powdered and Powder free) End User (Hospitals & Clinics, Diagnostic/Pathology Labs, and Others), and Regional Forecast, 2019-2026”. From its current standing at USD 5.4 billion, the global disposable medical gloves market value is projected to reach USD 10.9 billion during the forecast period, as per the report. Additionally, the report provides a detailed analysis of the factors and dynamics that will shape the market till 2026.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/disposable-medical-gloves-market-101484
Growing Popularity of Medical Tourism to Boost the Market
Medical tourism refers to travelling undertaken by patients to other countries to seek medical help either because healthcare in their country is unaffordable or is extremely weak. Medical tourism is increasing around the world, especially from the developed nations such as the US to developing nations such as India. For example, a study published in the American Journal of Medicine estimates that in 2017, about 1.4 million Americans and 14 to 16 million people all over the world toured different countries for healthcare. The top five most preferred destinations being Costa Rica, India, Malaysia, Mexico, and Singapore. According to a report by Visa and Oxford Economics, the value of the overall medical tourism industry is increasing annually by USD 439 billion. This will fuel the global disposable medical gloves market revenue till 2026.
Asia-Pacific to Showcase Splendid Growth; North America to Dominate
Having generated business worth USD 2 billion in 2018, North America is expected to hold a dominant portion in the global disposable medical gloves market share in the forecast period. The primary reasons for this being high awareness levels about safety of medical equipment, well-established distribution network, and growing demand for high quality disposable gloves. Similar factors are expected to drive the market in Europe as well and make the region the second largest stakeholder in the global disposable medical gloves market.
Asia-Pacific is expected to exhibit the most impressive growth rate among regions owing to the rising incidence of chronic and infectious diseases in the region, along with increasing production of medical equipment in India, China, and Bangladesh. Africa and the Middle East are anticipated to grow at a decent pace on account of increased healthcare spending and investment, which can expand the global disposable medical gloves market size.
More Trending Topics From Fortune Business Insights@
Incontinence Care Products Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The world’s first Healthable™ hearing aid namely Livio AI was reinvented by Starkey Hearing Technologies in August 2018. This updated hearing aid will run on AI and integrated sensors and is the first device to trace cognitive health and physical activity as measured by hearing aid for utilizing in social situations. Such innovations are likely to bode well for the global hearing aids market predicts Fortune Business Insights in their recent report titled, “Hearing Aids Market Size, Share & Industry Analysis, By Product (Hearing Devices, Hearing Implants), By Patient Type (Adult, Pediatric), By Distribution Channel (OTC (Over the Counter), Medical Channel/ Hospital Pharmacies, Private Practice/ Retail Pharmacies) and Regional Forecast, 2019-2026.” According to the report, the market was valued at USD 8.39 Billion in 2018 and is anticipated to reach USD 14.45 Billion by the end of 2026. The forecast period is set from 2019 to 2026 and the market is expected to rise at a CAGR of 7.2%.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/hearing-aids-market-101573
Hearing Devices Segment to Lead Market due to Cost-Efficient Feature
The report is based on primary and secondary research methods and provides an in-depth global hearing aids market analysis. The report covers all important aspects of the market such as growth drivers, restraints, trends, and opportunities. It also lists the profile of the companies operating in the hearing aid market with key insights that will help these vendors strategize for better revenue generation in the forecast duration.
As per the report, the hearing devices segment is currently dominating the market because of its numerous advantages. These include flexibility for patients with both mild and moderate hearing loss, easily removable, cost-effective, and can be used during sports activities as well. Such flexibility of the device and at reasonable prices are two important factors anticipated to promote the growth of this segment in the coming years.
Increasing number of ENT Clinics to Boost Market
The major factor promoting the growth of the market is the rising prevalence of hearing disorders among people. A study conducted by the World Health Organization in 2019 stated an estimate of about 900 million people worldwide who are likely to suffer from hearing loss by the end of 2050. The study also states about 1.1 billion people within the age group of 12 to 35 years are prone to hearing impairment because of exposure to noise in recreational settings. Such statistics clearly indicate the benefit of the global market in the near future.
Another factor promoting the market growth is the rise in the geriatric population. Besides this, governments are taking initiatives such as health benefit programs, awareness programs, setting up more ENT clinics, and others and this is also anticipated to boost the global market in the coming years.
However, certain factors may pose a challenge to the hearing aids market. Long term use of hearing aids may cause moisture in the ears or ear wax, and feedback problems. Moreover, the wrong size hearing aid may also result in handling problems. This may cause hindrance to the market in the long run. Therefore, manufacturers are focusing on production of a cleaning kit in order to maintain the cleanliness of these hearing devices. This may create lucrative growth opportunities for the market in the forecast period.
More Trending Topics From Fortune Business Insights@
Acute Bacterial Skin and Skin Structure Infections Treatment Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global asthma treatment market size is expected to reach USD 26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period. The growing incidence of respiratory diseases such of chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, lung cancer, asthma, and pleural effusion will spur demand for asthma treatment during the forecast period, mentioned in a report, titled “Asthma Treatment Market Size, Share & Industry Analysis, By Treatment (Long-Term Control Medications, and Quick-Relief Medications), By Route of Administration (Injectable, Oral, and Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Regional Forecast, 2020-2027” the market size stood at USD 18.08 billion in 2019. The increasing risk of death in asthma patients amid the COVID-19 pandemic will fuel demand for pre-diagnosis, which, in turn, will aid the market. For instance, According to the Centers for Disease Control and Prevention (CDC), during the 2019-2020 corona virus pandemic, individuals suffering from moderate to severe asthma, were at a greater risk of falling ill with acute respiratory disease.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/asthma-treatment-market-101039
Market Driver:
Surge in Asthma Cases to Expedite Business Expansion
The increasing prevalence of chronic respiratory diseases such as asthma has led to the expansion of the market during the forecast period. Asthma is considered to be the most common chronic disease worldwide. The growing need for advanced therapeutics will subsequently promote the growth of the market. According to the American Academy of Allergy, Asthma & Immunology (AAAAI), in the United States, in 2016, it was estimated that approximately 8.3% of children in the U.S. had asthma. The launch of low cost-effective therapeutics such as generic equivalents can be an essential factor in augmenting the growth of the market during the forecast period. The growing demand for asthma drugs due to the outbreak of coronavirus will significantly enable the healthy growth of the market. For instance, patients with chronic illnessessuch as asthma are more prone to catch the virus. The Centers for Disease Control and Prevention (CDC), in the time of coronavirus pandemic, has issued special guidelines to patients of asthma and also advocated greater precaution for asthma patients.
Market Restraint:
Expensive Asthma Medications to Dwindle Market Growth
The high costs associated with asthma inhalers, which are often considered the primary treatment for Asthma will limit the adoption of asthma therapeutics. For instance, the prices of Advair, a critical asthma drug has risen from US$ 316 in 2013 to US$ 496 in 2018, documenting an increase of 56.0%. Furthermore, the under diagnosis of asthma in developing countries will subsequently restrict the growth of the market during the forecast period. Under diagnosis of asthma leads to poor clinical outcomes for the patient and the adoption of in appropriate asthma pharmaceuticals as a treatment for their medical condition. These factors together are likely to restrict the growth of the market.
Regional Analysis:
Rising Awareness Among Patients to Support Growth in North America
The market size in North America stood at USD 9.40 billion in 2019. The growth in the region is attributed to the rising prevalence of asthma and the awareness of advanced and efficient asthma therapeutics among patients. The market in Asia Pacific is likely to hold the largest share in the forthcoming years owing to the presence of key products in the region, For instance, the strong growth of Pulmicort, a key asthma drug in China. The increasing prevalence of chronic respiratory diseases and growing launches of key products including efficient generic asthma therapeutics is predicted to bode well for the market in Asia Pacific during the forecast period.
More Trending Topics from Fortune Business Insights:
Mobility Devices Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global cardiac biomarkers market size is expected to reach USD 26.33 billion by 2027, exhibiting a CAGR of 11.2% during the forecast period. The growing incidence of critical cardiac conditions, including myocardial infarction, heart attack, and acute coronary syndrome (ACS) will subsequently inflate demand for cardiac biomarkers in the forthcoming years, mentioned in a report, titled “Cardiac Biomarkers Market Size, Share & Industry Analysis, By Indication (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, and Others), By Biomarker (Troponin, Creatine kinase-MB (CK-MB), B-type Natriuretic Peptide (BNP), Myoglobin, and Others), By EndUser (Hospitals, and Specialty Clinics), and Regional Forecast, 2020-2027” the market size stood at USD 13.15 billion in 2019. The increasing prevalence of cardiovascular diseases will spur opportunities for the market during the forecast period.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/cardiac-biomarkers-market-101233
Market Driver:
Cardiovascular Interventions to Promote Biomarkers Adoption
The increasing R&D investments by key players for the introduction of robust and novel cardiac biomarkers to benefit patients in diagnosis, prognosis and predictive analysis of cardiovascular disorders will enable speedy expansion of the market. The innovation in clinical cardiology and cardiovascular interventions can be an essential factor in fostering the growth of the market. Moreover, the increasing product launches by key players will augur well for the market in the forthcoming years. For instance, In July 2018, Siemens announced that it has received the U.S. Food and Drug Administration (FDA) approval for high-sensitivity troponin I assays (TnIH). The test will be beneficial in the early diagnosis of myocardial infarctions without the need for serial tropic testing. Similarly, in September 2019, Abbott unveiled ARCHITECT STAT High Sensitivity Troponin-I blood test after receiving the approval from the U.S. Food and Drug Administration (FDA) approval. The testwill help in detecting heart attacks in real-time, and more accurately than contemporary troponin tests.
Market Restraint:
Shortage of POC Testing Kits to Restrict Revenue Proliferation
The unavailability of POC testing kits and delayed test results of the laboratory-based tests will consequently restrict the growth of the market. The longer time periodrequired to obtain results from lab-based biomarker tests will dwindle the acceptance of biomarkers in the forthcoming years.For instance, creatine kinase-MB (CK-MB), a form of enzyme found in heart muscle cells can only be detected in a patient with a heart attack in about 3-6 hours after the onset of chest pain. Thus, the great deal of time required for evaluation or diagnosisofheart disease will restrict the market growth. In addition, the lack of awareness regarding cardiac biomarkers tests among patient population, and limited reimbursement for tests in the developing countries will obstruct the market.
Regional Analysis:
Increasing Prevalence of Cardiovascular Diseases to Propel Market in North America
The market in North America stood at USD 5.23 billion in 2019. North America is expected to the largest market share during the forecast period owing to the rising prevalence of cardiovascular diseases. For instance, as per the American College of Cardiology Foundation around about 1.05 million patients were suffering from coronary disorders in the United States in 2019. Europe is predicted to witness a high growth rate between 2020 to 2027 due to rising cases of acute coronary syndrome and myocardial infarction. Asia Pacific is likely to grow rapidly during the forecast period owing to the large patient population in the region. Moreover, the introduction of technologically advanced cardiac biomarkers will boost cardiac biomarkers market growth in Asia Pacific.
More Trending Topics from Fortune Business Insights:
Blood Glucose Meters Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global sleep apnea devices market size is predicted to reach USD 13.24 billion by 2027, exhibiting a CAGR of 6.8% during the forecast period. The rising cases of cardiovascular disorders and diabetes among the geriatric population have led to a surge in sleep apnea, which, in turn, will bolster the growth of the market during the forecast period, states Fortune Business Insights in a report, titled “Sleep Apnea Devices Market Size, Share &Covid-19 Impact Analysis, By Device Type (Therapeutic Devices, and Diagnostic Devices), By End User (Sleep Laboratories & Clinics, and Homecare & Other Settings), and Regional Forecast, 2020-2027” the market size stood at USD 7.81 billion in 2019.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/industry-reports/sleep-apnea-devices-market-100708
Market Driver:
Release of Advanced Devices to Aid Colossal Development
The development of new alternative devices owing to the escalating incidence will have a tremendous impact on the market. For instance,the introduction of the mandibular advancement device (MAD) for the treatment of OSA. The shift from CPAP devices to oral appliance owing to the discomfort caused by CPAP, can be a vital factor impelling manufacturers to launch alternative devices. Moreover, the effectiveness and comfort offered by oral devices will spur demand for such devices, which, in turn, will foster the growth of the market in the forthcoming years. The growing awareness regarding early diagnosis among patients will encourage the healthy growth of the market. The growing incidence of sleep apnea around the world will create opportunities for the market during the forecast period. In addition, the rising demand for advanced treatment and devices will spur opportunities for the market in the foreseeable future.
Shift towardsTelehealth & Homecare Model During Coronavirus Outbreak to Incite Business
The corona virus outbreak has disrupted the management of sleep apnea patients across the globe. Reduction in number of specific procedures in sleep labs due to the threat of corona virus has resulted in decline in number of new cases reported of sleep apnea during the pandemic. For instance according to the guideline provided by American Academy of Sleep Medicine, all the in-laboratory administration of PAP therapy and PSG diagnosis has been rescheduled or postpone during the COVID-19 pandemic. However, the introduction of several homecare model by pre-eminent players for sleep apnea patients will have a tremendous impact on the market. For instance, in March 2020, Oventus announced the launch of its Telehealth & homecare models to provide complete care to its patients suffering from obstructive sleep apnea (OSA).
Regional Analysis:
Rising Adoption of Innovative Therapeutics to Boost Market in North America
The market in North America generated a revenue of USD 3.77 billion in 2019 and is predicted to grow rapidly during the forecast period. The favorable reimbursement policies will enable speedy expansion of the market. The growing adoption of advanced treatment devices will further foster growth in the region. According to the American Academy of Sleep Medicine (AASM), an estimated 26% of the adult population in the U.S., was suffering from sleep apnea in 2018. Europe is expected to rise exponentially during the forecast period owing to the rising awareness about sleep apnea in the region. The increasing number of diagnostic tests along with the high adoption of advanced treatment devices will propel market in Europe. Asia Pacific is predicted to witness an excellent growth rate during the forecast period due to the rising cases of sleep apnea.
More Trending Topics from Fortune Business Insights:
Incontinence Care Products Market , Share, Growth, Sales and Drivers Analysis Research Report 2026
The global anti-inflammatory market size is expected to reach USD 191.42 billion by 2027 on account of increasing investments on the development of biologics for treating autoimmune inflammatory diseases. Anti-inflammatory drugs help to reduce inflammation in the body and treat health conditions such as arthritis, asthma, rheumatoid arthritis, sinusitis, and others. A recently published report by Fortune Business Insights offers a comprehensive overview of the market and its prime growth trajectories. As per the report titled, “Anti-Inflammatory Drugs Market Size, Share & Industry Analysis, By Drug Class (Anti-inflammatory Biologics, Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids), By Application (Autoimmune Inflammatory Diseases (Rheumatoid Arthritis Psoriasis, and Others), Respiratory Diseases, and Others), By Route of Administration (Oral, Injection, Inhalation, and Topical), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027,” the value of the market was USD 93.88 billion in 2019 and is expected to rise at a CAGR of 9.3% between 2020 to 2027.
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of corona virus outbreak across industries to help you prepare for the future.
Click here to get the short-term and long-term impact of COVID-19 on this [Market].
For More Information : https://www.fortunebusinessinsights.com/anti-inflammatory-drugs-market-102825
What are the Objectives of the Report?
The report offers a comprehensive overview of the market and its growth parameters such as drivers, restraints, challenges, and upcoming opportunities. The report also offers interesting insights into the market, current trends, and significant industry developments. It also throws light on key players functioning in the market and the key strategies adopted by them to compete for the top position. The report further discusses the segmentation of the market based on factors such as drug-class, application, route of administration, distribution channel, and geography, and lists the names of the leading segment with attributed factors. The report offers an overall qualitative and quantitative analysis of the market and is available for sale on the company website.
Market Drivers
Increasing Prevalence of Inflammatory Diseases will Add Impetus to Market
The increasing prevalence of inflammatory diseases namely ulcerative colitis, inflammatory bowel, psoriasis, and rheumatoid arthritis, and othersare the major anti-inflammatory drugs market growth driver.As per the Centers for Disease Control and Prevention, an estimate of 78 million people in the U.S. will be diagnosed with arthritis by the end of 2040. Apart from this, the increasing uptake of corticosteroids for treating chronic obstructive pulmonary diseases (COPD) and asthma, coupled with the increasing prevalence of atopic dermatitis are likely to aid in the expansion of the market in the long run.
On the contrary, the side effects of using non-steroids anti-inflammatory drugs or NSAIDs such as dizziness, allergic reactions, stomach pain, stomach ulcers, and others may pose a major threat to the market in the coming years. This, coupled with the risk of gastrointestinal bleeding and other complications may hinder the market in the coming years.
Regional Segmentation
North America to Emerge Dominant with Favorable Reimbursement Policies
Geographically, the market is dominated by North America with the rising demand for anti-inflammatory biologics, and government support for their launches. In 2019, North America earned a revenue of USD 41.39 billion, attributed to the massive investments in research and development that further expanded the regional market. The market in Europe, on the other hand, is likely to witness significant growth on account of active government support for launching biosimilars, and favorable health reimbursement policies. Moreover, the market in Asia Pacific will rise at a rapid speed on account of improving healthcare infrastructure and facilities, coupled with the increasing geriatric population, and rising preference for generic corticosteroids and NSAIDs. Furthermore, the Middle East and Latin American markets will gain momentum on account of the growing incidences of rheumatoid arthritis and improving healthcare infrastructure in the respective regions.
More Trending Topics from Fortune Business Insights:
Retinal Disease Therapeutics Market , Share, Growth, Sales and Drivers Analysis Research Report 2026